Theodore S. Johnson, MD, PhD
Augusta University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Theodore S. Johnson, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:26 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05106296 · Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTheodore S. Johnson · recruiting · Ependymoma, Medulloblastoma, Glioblastoma · principal investigator
- Ph2NCT04049669 · Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPGTheodore S. Johnson · active not recruiting · Glioblastoma, Medulloblastoma, Ependymoma
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Chemo-radio immunotherapy for pediatric brain tumorsR01CA229646 · NCI · AUGUSTA UNIVERSITY · PI Theodore S Johnson, David H. Munn · fiscal years 2019 to 2023Named on NCT04049669
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in medulloblastoma.